Meet Marta Motta, Director of Client Solutions for Welocalize Life Sciences.

Marta is responsible for implementing best practices, processes and technology solutions for life sciences industry customers. She works closely with the sales team to ensure that the company’s philosophy, Customer First, is implemented in every aspect of day-to-day activities.

Find out more about Marta.

Hire date: 4 January 2016

Where were you born?  I was born in Varese, Italy, a small town near Lake Maggiore. It is near Lake Como, which is widely popular now thanks to George Clooney.

Languages spoken: Italian, English and Spanish.

What did you study at university? I studied Languages at the Milan State University and then Translations in London at the London Metropolitan University.

If you could learn any language, which would you pick and why? Russian, I studied it for three years, but I need to pick it up again.

What are you most proud of (personally and professionally)? Professionally, I’m very proud of the team I’m working with and all the amazing things we have achieved in a very short period of time, including two acquisitions. Personally, I’m very proud of my family.

You are presenting in the Digital Health track for DIA Annual Canadian Meeting. What trends in technology are you seeing in the clinical trial space? It’s a very exciting time in the healthcare sector. Even though, it is quite a traditional environment, lately we have seen many changes especially on the technology development front. More and more companies are utilizing technology to handle and track clinical trial documentation not only in relation to eTMF, but they have started utilizing portal and clinical trial platforms to actively manage and share documents during the trial. We are seeing the implementation of ePROs and more and more we are reaching out to patients through social media and new channels.

How can these technology tools improve the clinical trial process? The global clinical trials market size was valued at $40 billion in 2016 and is expected to reach $65 billion by 2025, according to a 2017 report by Grand View Research. This growth is global, meaning sites and studies are happening in more countries, which directly increases complexity. All these changes have resulted in the need to have solid technology that can help coordinate the handling of those various documents. A Clinical Trials Portal provides a safe repository and tracking system for all the documents submitted to a translation agency. We also know that often there are several versions of documents. Having all those stored in a secure platform allows the user to easily retrieve and update them.

What life sciences publications or resources do you recommend? Attending industry conferences is key, as they are very informative. In fact, I recently attended and presented at the DIA Annual Canadian Meeting. I also always read the news sections of our customers’ website. As for life sciences publications, I like BioPharma Reporter.

Do you have a bucket list? What is something you are hoping to check off the list soon? Next on my bucket list is improving my yoga practice. I have been doing it for few years, but I do feel I need to dedicate a bit more time in order to improve my practice.

What travel destination is next on your list and why? My next trip will be to Ottawa, I have never been to Canada, so I decided to stay there the weekend after the DIA Annual Canadian Meeting to explore the city and Canadian culture. Soon after I will escape to much needed sun in Thailand.